U.S. reform of federal medical marijuana laws is giving a boost to cannabis stocks, and there appears to be more upside ...

Curaleaf CEO Jordan says institutional investors are finally engaging with cannabis. Here's why that shift - and his ...

The post-280E era will usher in new winners among cannabis stocks.

Canopy Growth (NASDAQ: CGC) reported huge growth in its medical marijuana business, which saw revenues increase 27% in the ...

Cannabis companies are racing the clock to list on the NYSE, as Glass House applies. A DEA hearing beginning on June 29 could ...

Cannabis stocks jumped on April 23 when the U.S. Department of Justice announced it was reclassifying cannabis from a Schedule I to a Schedule III drug. When the smoke cleared, however, and investors ...

Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and ...

Trulieve's upcoming NYSE listing follows the Trump administration's decision to reclassify medical marijuana under federal law.

For an industry that's spent half a decade stuck in existential purgatory, this is what a revival looks like. Tilray's premarket rocket — up nearly 30% — wasn't just policy spillover. The company's ...

This year has been a roller coaster for the massive California cannabis grower.

Trump is reportedly considering easy some restrictions on cannabis, and investors are piling into the sector on Friday.

A U.S.-based marijuana company is now trading on the New York Stock Exchange.